People with the condition need to closely monitor their diet and activity and may need to take medications as their blood sugar becomes more difficult to manage
Therefore, although the study is interesting from a biological standpoint and may be useful for generating hypotheses or for future, more comprehensive predictive models, the results alone do not yet justify direct clinical application or the routine use of genetic testing to guide treatment
Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of cisplatin nephrotoxicity
As anticipated, among those patients who remained on treatment with semaglutide by the EOS, 78.2% and 78.9% of those in the low/no CKD risk cohort and CKD cohort, respectively, were being administered the full dose of 1 mg weekly at that time whereas only one patient remained with the initial dose of 0.25 mg weekly